observed a permanent relocation of FAT/CD36 to the sarcolemma in skeletal muscle of type 2 diabetic patients leading to a marked increase in skeletal muscle fatty acid transport (Bonen et al. Here, CD36 is linked to type 2 diabetes mellitus.